Navigation Links
Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Date:10/10/2008

NATICK, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its second-generation TAXUS(R) Liberte(R) Paclitaxel-Eluting Coronary Stent System. The Company plans to launch the TAXUS Liberte stent early next month in the United States, following completion of the introduction of its TAXUS(R) Expresss2(TM) Atom(TM) Paclitaxel-Eluting Coronary Stent System, which was approved by the FDA last month. The TAXUS Liberte stent was launched in Europe and other international markets in 2005.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/bsci/34446/

"The TAXUS Liberte stent represents our latest advance in drug-eluting stent technology," said Donald Baim, M.D., Chief Medical and Scientific Officer of Boston Scientific. "This device has substantially thinner struts and a more flexible cell geometry for improved deliverability, as well as uniform strut distribution designed specifically for drug elution. The TAXUS Liberte stent demonstrated similar late loss and target vessel revascularization (TVR) as the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System in the ATLAS Workhorse clinical trial, despite treating more challenging patients."

"We believe the approval of TAXUS Liberte is a clear indication that we have made significant progress toward resolving the issues related to the Corporate Warning Letter," said Jim Tobin, President and Chief Executive Officer of Boston Scientific.

The TAXUS stent systems -- both Liberte and Express2 -- have been evaluated by the industry's most
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related biology technology :

1. Video: Women Unsatisfied With Body and Breasts, Less Likely to Comply With Screenings, Including Mammography
2. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder
3. Video: Fortune 1000 Executives: New President Must Fix Education Gap
4. Video: Keppra XR(TM) Approved in the U.S.
5. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
6. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
7. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
8. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
9. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
10. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
11. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
(Date:11/6/2009)..., November 6 EUCODIS Bioscience, a...nd marketing enzymes for the,chemical industry ann...greement with Bio Sidus, the leading biopharmaceut...ement gives EUCODIS Bioscience exclusive access - ...us, proprietary collection of,psychrophilic bacter...
(Date:11/6/2009)...Newswire-FirstCall/ - Oncolytics Biotech Inc. (TSX... today announced updated results from a Phase II s...arcomas metastatic to the lung in a poster present...y Society Meeting held in Miami Beach, Florida, fr...ntitled "A Phase II Study of Intravenous REOLYSIN ...
(Date:11/5/2009)...ne hybrid . . . , Fuel economy ratings for the... the www.fueleconomy.gov web site, which Oak Rid... the U.S. Department of Energy and the U.S. Enviro...cles on the best fuel economy list are hybrid elec...ghway). "This list proves that hybrids have gone m...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...,(Nasdaq: MAXY ), a biotechnology company focused...ay announced that it will present at the,JPMorgan ...ry 7, 2008 at,9:00 a.m. Pacific Time. Russell Howa...Vetticaden, Maxygen,s chief medical officer, will ... accessed on Maxygen,s website at, http://www.maxy...
...ber 28, 2007 at 8:30 a.m ...xza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) today a...opment partnership with Endo Pharmaceuticals Holdi...fentanyl) and the fentanyl,class of molecules for ...opment, AZ-003 is a hand-held drug device that use...
...Science from Faux Science, NORTH KINGSTOWN, R.I.,...Society, Dominion Diagnostics sponsored an extensi...eview of Urine Drug Testing:,Which Test, Which Pat...ence," presented by Dr. Robert Barkin, Pharm.D, MB...r, Faculty of Anesthesiology, Family,Medicine, and...
Other Biology Technology:Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 2Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 3Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 4Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America 5Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics 2
(Date:11/9/2009)..., , BIRMINGHAM, Ala. The U.S. Department of Ener...he University of Alabama at Birmingham (UAB) Schoo...educe greenhouse gas emissions through the capture...carbon dioxide (CO2). The project is in collaborat...labama Power. , Funded by the DOE through the 20...
(Date:11/9/2009)..., The brilliance of butterfly wings has inspire...s to deliver innovation in the fields of security,...ter and international technology company QinetiQ h...p new technologies based on groundbreaking physica...s a team of physicists from the University of Exet...
(Date:11/9/2009)..., PHILADELPHIA Scientists and industry leaders f...-19, 2009, for the AACR-NCI-EORTC Molecular Target..., which will feature groundbreaking information on...Cancer is a complex disease and to treat it effect...ity that takes place at the molecular level," said...
Breaking Biology News(10 mins):UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Nuvilex Introduces Last Shot Hangover Remedy 28TM 29 Video 55546 1Nuvilex Introduces Last Shot Hangover Remedy 28TM 29 Video 55546 2The Cosmetic Bootcamp LLC Announces Novel Presentations at Its 3rd Annual Marketing and Management Symposium 55542 1White House Sued Over Free Speech Violations In Healthcare Battle 3A Doctor 26 Patient Groups Say White House Intended to Shut Up Opponents 55538 1White House Sued Over Free Speech Violations In Healthcare Battle 3A Doctor 26 Patient Groups Say White House Intended to Shut Up Opponents 55538 2
...ARY 23, 2009 The legacy of nuclear weapons and nu... sediment at dozens of sites across the United Sta...th uranium. The uranium is transported through gro...trategy, uranium immobilization in contaminated gr...ition of organic molecules known as electron donor...
... light emission by living organisms, bioluminescen... It is known that light is generated by chemical r...nt part. In the animal world, these chemical react...d photocytes. These are aggregated into complex li...ulated by nerve impulses, and in which light can b...
... diet at the time we are conceived set the course ... at the heart of a new study based on an "experime...nded researchers. , We inherit our DNA the genet... parents: 50% of our DNA from our mothers and 50% ...on, deletion or duplication of information, this D...
Other Biology News:Patience pays off with methanol for uranium bioremediation 2New light shed on marine luminescence 2'Experiment of nature' examines how mother's diet may impact on child's health 2'Experiment of nature' examines how mother's diet may impact on child's health 3
iEMS thermal microplate holder from Thermo Scientific
Deluxe CO2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
LN2 Backup, Factory Installed, All Voltages, for 3.0 and 6.7 cu ft -86C Chest Freezers & all -40C/ -86C Upright Freezers from Thermo Scientific
...se H- Reverse Transcriptase (RT) is an improved ve... a DNA polymerase that synthesizes a complementary...:DNA hybrid. This enzyme is genetically engineered...n a deletion in the RNase H active center. Like Su...
Biology Products: